|
PRPF18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.263900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.752400E-02 |
| Normal-vs-Stage2 |
1.13729999995371E-06 |
| Normal-vs-Stage3 |
3.534500E-02 |
| Normal-vs-Stage4 |
3.977200E-01 |
| Stage1-vs-Stage2 |
1.954870E-04 |
| Stage1-vs-Stage3 |
6.522800E-01 |
| Stage1-vs-Stage4 |
4.938200E-01 |
| Stage2-vs-Stage3 |
4.120900E-03 |
| Stage2-vs-Stage4 |
9.974400E-04 |
| Stage3-vs-Stage4 |
3.582600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.299800E-03 |
| Normal-vs-AfricanAmerican |
8.823600E-01 |
| Normal-vs-Asian |
1.281420E-01 |
| Caucasian-vs-AfricanAmerican |
1.012210E-01 |
| Caucasian-vs-Asian |
7.003000E-01 |
| AfricanAmerican-vs-Asian |
2.291000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.857000E-03 |
| Normal-vs-Female |
2.388400E-02 |
| Male-vs-Female |
1.988160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.813600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.420500E-03 |
| Normal-vs-Age(61-80Yrs) |
8.519600E-03 |
| Normal-vs-Age(81-100Yrs) |
9.827200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.593560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.624400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.086800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.059600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.731800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.630400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.749200E-01 |
| Classical-VS-Follicular |
5.65569999999571E-05 |
| Classical-VS-Other |
4.248400E-01 |
| Classical-VS-Normal |
1.149350E-01 |
| Tall-VS-Follicular |
1.338100E-03 |
| Tall-VS-Other |
2.226600E-01 |
| Tall-VS-Normal |
9.586400E-01 |
| Follicular-VS-Other |
5.896000E-01 |
| Follicular-VS-Normal |
1.76844999999481E-05 |
| Other-VS-Normal |
1.168840E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.43209999999383E-05 |
| Normal-vs-N1 |
5.491600E-01 |
| N0-vs-N1 |
3.132100E-02 |
|
|
